Red Blood Cells in Clinical Proteomics.

Area of Science:

• Biochemistry
• Cell Biology
• Parasitology

Background:

• Red blood cells (RBCs) are vital for oxygen and carbon dioxide transport, linking them to diseases causing tissue hypoxia.
• RBCs are targets for parasitic infections like malaria and serve as indicators for other systemic diseases due to their abundance and circulation.
• RBC membrane components are potential drug targets for antiparasitic therapies, and RBCs' role in cancer is an emerging area of research.

Purpose of the Study:

• To detail methods for isolating erythrocytes and fractionating them into membrane and cytosolic components.
• To present procedures for mass spectrometry-based proteomic analysis of the RBC membrane.
• To highlight the significance of RBC proteome analysis for understanding disease mechanisms and drug discovery.

Main Methods:

• Erythrocyte isolation from whole blood.
• Fractionation of RBCs into membrane and soluble cytosolic components.
• Mass spectrometry-based proteomic analysis of RBC membrane.

Main Results:

• Established protocols for RBC fractionation.
• Characterized RBC membrane and cytosolic proteomes.
• Identified potential drug targets within RBC membrane components.

Conclusions:

• RBC proteome analysis, especially of the membrane, provides valuable insights into diseases like malaria and cancer.
• The described methods facilitate the study of RBCs as diagnostic indicators and therapeutic targets.
• Further research into RBCs can lead to novel drug discovery strategies against parasitic diseases and cancer.